Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study
NCT05059184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2450
Last updated 2025-07-03
Summary
The term recovery from COVID-19 caused by SARS-CoV-2 is unverified because the infection leaves many symptoms due to permanent effects on multiple organs; The primary objective of this research is to understand acute and chronic long COVID symptoms by asking questions detecting patient's experience especially symptoms lasting for several months which is known as chronic fatigue syndrome(Myalgic encephalitis). The study focuses on symptoms describing Myalgic encephalitis which may still affect COVID patients for several months after the infection along with making a big picture about rare symptoms that may the patient experienced during or after the infection.
A secondary objective of this research is to focus on the long-term sequelae effects and comorbidities following COVID-19 vaccination.
Conditions
- Myalgic Encephalomyelitis
Interventions
- OTHER
-
This is an observational cross-sectional study, there is no need for intervention
This is an observational cross-sectional study. There is no need for intervention
Sponsors & Collaborators
-
Alexandria University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2022-07-01
- Completion
- 2022-09-01
Countries
- Egypt
Study Locations
More Related Trials
-
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
NCT00001764 ·Status: COMPLETED ·Phase: PHASE1
-
Retrospective Comparison of the Efficacy of Methotrexate and Azathioprine as Background Treatment for Uveitis of Undetermined Origin: Single-centre Retrospective Study From 2005 to 2020
NCT05370690 ·Status: UNKNOWN
-
Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study
NCT05074706 ·Status: COMPLETED
-
Etiology of Lymphopenia in Covid19 Infection
NCT04404608 ·Status: COMPLETED
-
FMF and Atheroscelerosis
NCT06047938 ·Status: NOT_YET_RECRUITING
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH
NCT04347460 ·Status: UNKNOWN
-
To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID
NCT05911009 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients
NCT01854814 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
NCT05190991 ·Status: RECRUITING ·Phase: PHASE2
-
Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
NCT00301600 ·Status: COMPLETED ·Phase: NA
-
Multicenter, Uncontrolled Pilot Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies
NCT05702996 ·Status: UNKNOWN ·Phase: PHASE3
-
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
NCT06721234 ·Status: RECRUITING
-
Short-term Glucocorticoid Combined with MMF for IgG4-RD
NCT06663618 ·Status: RECRUITING ·Phase: NA
-
Quality of Life in Patients With Auto-inflammatory Diseases
NCT03569644 ·Status: COMPLETED ·Phase: NA
-
Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis
NCT02910258 ·Status: COMPLETED
-
Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their Siblings
NCT05488561 ·Status: UNKNOWN ·Phase: NA
-
MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
NCT05495893 ·Status: UNKNOWN ·Phase: PHASE4
-
Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis
NCT02874586 ·Status: UNKNOWN ·Phase: NA
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
NCT00004567 ·Status: COMPLETED ·Phase: PHASE2
-
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
NCT00103792 ·Status: COMPLETED ·Phase: PHASE3
-
Mobile App-Based Infection Monitoring in Familial Mediterranean Fever
NCT07212764 ·Status: ENROLLING_BY_INVITATION
-
Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
NCT00414128 ·Status: COMPLETED ·Phase: PHASE2/PHASE3